News FDA backs Astellas/Seattle Genetics bladder cancer drug The FDA has quickly okayed Astellas and Seattle Genetics’ advanced bladder cancer drug enfortumab vedotin, one of the stars of this year’s ASCO conference that was considered an almost dead
News Novo Nordisk partners Amazon on London AI hub Novo Nordisk has joined forces with Amazon Web Services on a project that will lead to the creation of an AI co-innovation hub in London.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.